Professor of Ophthalmology at the Bascom-Palmer Eye Institute
Pro to the question "Should Marijuana Be a Medical Option?"
"In the case of smoked marijuana or Marinol, it's quite clear that it does lower intraocular pressure, often substantially. ... So I don't think there's any doubt about its effectiveness, at least in some people with glaucoma."
"National Institutes of Health (NIH) Workshop on the Medical Utility of Marijuana Roundtable Discussion," Feb. 20, 1997
Key Experts Physicians [Physicians are the "key experts" in the medical marijuana debate because the issue is thought by many to be ultimately based on the medical value and risks of marijuana, and Physicians, with their training and clinical work, should (at least in theory) have the best knowledge of marijuana's medical value and risks.] [Note: Key Experts definition varies by sites that have this designation.]
Involvement and Affiliations:
Professor of Ophthalmology, Bascom-Palmer Eye Institute
Conducted research on how marijuana can be an effective therapeutic drug for glaucoma
One of eight panelists for National Institute of Health's (NIH) Feb. 19, 1997 review of existing science regarding medicinal marijuana
Certified by the American Board of Ophthalmology
PhD, Northwestern University Graduate School, Chicago, IL
MD, Northwestern University Medical School, Chicago, IL
Residency: Department of Ophthalmology, Washington University School of Medicine, St. Louis, MO
Research Fellowship, Department of Ophthalmology, Washington University School of Medicine, St. Louis, MO